Archives
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
GSK343 and the Precision Epigenetic Revolution: Mechanist...
2025-10-06
This thought-leadership article explores the state-of-the-art in EZH2 inhibition, focusing on the mechanistic, experimental, and translational impact of GSK343. By integrating new findings around telomerase regulation and chromatin dynamics—including the pivotal role of APEX2 in TERT expression—this article offers unmatched strategic guidance for translational researchers aiming to leverage selective EZH2 methyltransferase inhibitors. With detailed experimental rationale, competitive positioning, and future-facing perspectives, it extends far beyond standard product pages, mapping the frontier where epigenetic research meets clinical innovation.
-
Oxaliplatin in Advanced Tumor Assembloid Models: Applied ...
2025-10-05
Harness the power of Oxaliplatin, a third-generation platinum-based chemotherapeutic agent, for translational cancer research using next-generation tumor assembloid systems. Discover stepwise experimental workflows, real-world troubleshooting tips, and how DNA adduct formation in complex microenvironments revolutionizes metastatic colorectal cancer therapy and beyond.
-
MLN4924: Next-Generation NEDD8-Activating Enzyme Inhibito...
2025-10-04
Explore MLN4924, a potent NEDD8-activating enzyme inhibitor, and its advanced applications in cancer biology research. This article uniquely delves into the latest mechanistic discoveries and translational opportunities, highlighting how MLN4924 is shaping anti-cancer therapeutic development and neddylation pathway inhibition.
-
Preserving the Phosphorylation Code: Strategic Advances i...
2025-10-03
This thought-leadership article unpacks the mechanistic and translational imperatives for rigorous protein phosphorylation preservation in cutting-edge telomerase and stem cell studies. Framed by landmark findings on TERT regulation and APEX2’s role in human embryonic stem cells, it offers strategic guidance on leveraging dual-component phosphatase inhibitor cocktails—specifically the Phosphatase Inhibitor Cocktail (2 Tubes, 100X)—to safeguard signaling fidelity. The narrative situates this approach within the evolving competitive and translational landscape, providing actionable insights for researchers aiming to elevate the reproducibility and clinical impact of their phosphoproteomic workflows.
-
Gastrin I (human): Catalyzing Advanced Gastric Acid Secre...
2025-10-02
Gastrin I (human) empowers researchers to dissect gastric acid secretion pathways with unprecedented precision in organoid and cell-based models. This peptide's high purity and robust receptor agonism make it essential for studying gastrointestinal physiology, disease mechanisms, and therapeutic screening. Discover optimized protocols, troubleshooting insights, and how Gastrin I (human) sets a new benchmark for experimental reproducibility.
-
Brefeldin A: ATPase Inhibitor Revolutionizing Vesicle Tra...
2025-10-01
Brefeldin A (BFA) delivers unmatched precision as an ATPase inhibitor and vesicle transport disruptor, empowering researchers to dissect protein trafficking and ER stress in cancer and endothelial systems alike. Its robust, reproducible effects make it a cornerstone for analyzing apoptosis, migration, and stress signaling, particularly in challenging translational models.
-
Cy3 TSA Fluorescence System Kit: Advancing Transcriptiona...
2025-09-30
Explore how the Cy3 TSA Fluorescence System Kit leverages tyramide signal amplification to enable advanced detection of transcriptional and lipogenic pathway alterations in cancer. This in-depth article uniquely connects fluorescence amplification technology to the molecular study of de novo lipogenesis and transcriptional regulation, offering actionable insight beyond conventional applications.
-
5-Ethynyl-2'-deoxyuridine (5-EdU): Precision Tools for S ...
2025-09-29
Discover the advanced mechanisms and unique advantages of 5-Ethynyl-2'-deoxyuridine (5-EdU) for click chemistry cell proliferation detection. This article uniquely explores 5-EdU’s role in high-fidelity S phase DNA synthesis analysis and its transformative impact on stem cell and reproductive biology.
-
EZ Cap™ Human PTEN mRNA (ψUTP): Redefining mRNA Therapeut...
2025-09-28
Explore the scientific foundations and translational potential of EZ Cap™ Human PTEN mRNA (ψUTP), a human PTEN mRNA with Cap1 structure, for cancer research and mRNA-based gene expression studies. This article uniquely dissects mechanistic advances, clinical implications, and future directions beyond existing content.
-
Rucaparib (AG-014699): Precision Radiosensitizer Targetin...
2025-09-27
Explore how Rucaparib (AG-014699, PF-01367338), a potent PARP inhibitor, uniquely enables advanced DNA damage response research and radiosensitization in PTEN-deficient and ETS fusion-expressing cancer models. This article unveils new mechanistic links between DNA repair inhibition and transcription-coupled cell death, offering a distinct perspective for cancer biology research.
-
Next-Gen mRNA Tools: EZ Cap Cy5 Firefly Luciferase mRNA f...
2025-09-26
Discover how EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) revolutionizes mammalian gene expression with Cap1 capping, 5-moUTP modification, and Cy5 fluorescence. This article offers unique mechanistic insights and advanced applications in translation efficiency, imaging, and immune modulation.
-
ABT-737 and RNA Pol II: Integrating BCL-2 Inhibition with...
2025-09-25
Explore how the BCL-2 protein inhibitor ABT-737 intersects with newly discovered RNA Pol II-dependent apoptosis pathways, revealing advanced strategies for targeted cancer research. This article provides a unique synthesis of mechanistic, translational, and experimental insights.
-
VX-765: Advanced Caspase-1 Inhibitor Applications in Cell...
2025-09-24
Explore how VX-765, a selective caspase-1 inhibitor, redefines approaches to inflammatory cytokine modulation and cell death pathways. This article provides a unique synthesis of VX-765’s mechanistic action, integration with novel apoptotic insights, and its transformative role in translational research.
-
Murine RNase Inhibitor: Advancing RNA Stability for Circu...
2025-09-23
Explore the unique oxidative stability and specificity of Murine RNase Inhibitor, a recombinant protein essential for RNA degradation prevention in advanced molecular biology assays, including applications in cutting-edge circular RNA vaccine research.
-
The fat body is one
2025-03-03

The fat body is one of the largest tissues of Bombyx mori, with components including fat, glycogen, protein and vitamins. The fat body exhibits important physiological functions, not only storing a large number of nutrients but also serving as an important site of biosynthesis and metabolism (Arrese
15294 records 8/1020 page Previous Next First page 上5页 678910 下5页 Last page